Geranylgeranylated Proteins Are Involved in the Regulation of Myeloma Cell Growth

Total Page:16

File Type:pdf, Size:1020Kb

Geranylgeranylated Proteins Are Involved in the Regulation of Myeloma Cell Growth Vol. 11, 429–439, January 15, 2005 Clinical Cancer Research 429 Geranylgeranylated Proteins are Involved in the Regulation of Myeloma Cell Growth Niels W.C.J. van de Donk,1 Henk M. Lokhorst,3 INTRODUCTION 2 1 Evert H.J. Nijhuis, Marloes M.J. Kamphuis, and Multiple myeloma is characterized by the accumulation Andries C. Bloem1 of slowly proliferating monoclonal plasma cells in the bone Departments of 1Immunology, 2Pulmonary Diseases, and 3Hematology, marrow. Via the production of growth factors, such as University Medical Center Utrecht, Utrecht, the Netherlands interleukin-6 (IL-6) and insulin-like growth factor-I (1–4), and cellular interactions (5, 6), the local bone marrow microenvironment sustains tumor growth and increases the ABSTRACT resistance of tumor cells for apoptosis-inducing signals (7). Purpose: Prenylation is essential for membrane locali- Multiple signaling pathways are involved in the regulation of zation and participation of proteins in various signaling growth and survival of myeloma tumor cells. Activation of the pathways. This study examined the role of farnesylated and Janus-activated kinase-signal transducers and activators of geranylgeranylated proteins in the regulation of myeloma transcription (8), nuclear factor-nB (9–11), and phosphatidy- cell proliferation. linositol 3V-kinase (PI-3K; refs. 4, 12, 13) pathways has been Experimental Design: Antiproliferative and apoptotic implicated in the protection against apoptosis, whereas effects of various modulators of farnesylated and geranyl- activation of the PI-3K (4, 12, 13), nuclear factor-nB (10, 11), geranylated proteins were investigated in myeloma cells. and mitogen-activated protein kinase pathways (14) induces Results: Depletion of geranylgeranylpyrophosphate proliferation in myeloma cell lines. inhibited myeloma cell proliferation through accumulation GTPases of the Ras and Rho families cycle between an of cells in G phase of the cell cycle and loss of cells in S phase. 1 inactive GDP-bound form and a GTP-bound form with affinity In contrast, depletion of farnesylpyrophosphate had no or for various effector proteins that control signal transduction only minor effects. Furthermore, inhibition of geranylger- cascades regulating multiple cellular processes, including anyl transferase I activity was more effective in reducing migration, cytoskeletal reorganization, stimulation of cell myeloma cell growth when compared with inhibition of proliferation, and survival. Activating Ras mutations are farnesyl transferase activity. This indicates that protein frequently detected in myeloma (15–17) and contribute to geranylgeranylation is important for myeloma cell prolifer- reduced apoptosis (18, 19), increased cell proliferation (18, 19), ation and cell cycle progression through G . Geranylgerany- 1 and an adverse clinical outcome (15, 17). Rac-1, Cdc42, and lated target proteins involved in the control of proliferation RhoA have been implicated in the regulation of cell cycle include GTPases, such as Rac-1, Cdc42, and RhoA. progression through G phase of the cell cycle. Constitutively Inhibition of Rho, Rac, and Cdc42 GTPases by toxin B 1 activated mutants of Rac-1, Cdc42, and RhoA caused G reduced proliferation, without affecting cell viability, where- 1 progression and stimulation of DNA synthesis in fibroblasts as specific inhibition of Rho GTPases by C3 exoenzyme was (20–22). Furthermore, expression of active forms of Rac-1, without effect. This suggests a role for Rac and/or Cdc42 Cdc42, and RhoA can transform fibroblasts (23, 24), and GTPases in myeloma cell growth. Rac-1 activity was found in activation of Rac-1, RhoA, and Cdc42 is required for full Ras all myeloma cell lines and was suppressed by the depletion of transforming activity (25–27). The role of Rac, Cdc42, and intracellular pools of geranylgeranylpyrophosphate, whereas RhoA in multiple myeloma is currently unknown. interleukin-6 rapidly induced Rac-1 activation. Furthermore, dominant-negative Tat-Rac-1 reduced myeloma cell prolif- Participation of Ras and Rho family proteins in signaling eration, whereas constitutively active Tat-Rac-1 enhanced pathways depends on their proper subcellular localization to the proliferation. plasma membrane, which is facilitated by a series of post- Conclusion: These results indicate that protein gera- translational modifications of the carboxyl terminus (28–30). nylgeranylation is essential for myeloma cell proliferation This includes the addition of a farnesyl lipid side chain by and suggest that Rac-1 is a regulator of myeloma cell growth. farnesyl transferase (farnesylation) or a geranylgeranyl lipid side chain by geranylgeranyl transferase I (geranylgeranylation) to a conserved cysteine residue at the carboxyl terminus of proteins ending in CAAX, where C is cysteine and A is an aliphatic amino Received 6/29/04; revised 10/5/04; accepted 10/14/04. acid. The protein will be farnesylated when X is methionine, Grant support: Dutch Cancer Society. serine, cysteine, or glutamine and geranylgeranylated when X The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked is leucine or isoleucine. Target proteins include Ras, which is advertisement in accordance with 18 U.S.C. Section 1734 solely to predominantly farnesylated, and Rho family proteins, such as indicate this fact. Rac-1, Cdc42, and RhoA, which are geranylgeranylated. The Requests for reprints: Andries C. Bloem, Department of Immunology, farnesyl and geranylgeranyl lipids used for protein prenylation University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands. Phone: 31-30-2506511; Fax: 31-30-2517107; are derived from farnesylpyrophosphate (FPP) and geranylger- E-mail: [email protected]. anylpyrophosphate (GGPP), respectively. FPP and GGPP are D2005 American Association for Cancer Research. produced in the mevalonate pathway. The rate-limiting step of Downloaded from clincancerres.aacrjournals.org on September 30, 2021. © 2005 American Association for Cancer Research. 430 Geranylgeranylated Proteins Mediate Myeloma Cell Growth this pathway is the conversion of 3-hydroxy-3-methylglutaryl- The plasma cell percentage in the patient samples varied from 15% CoA (HMG-CoA) to mevalonate, which is catalyzed by the to 96% of the mononuclear cells as determined by coexpression of enzyme HMG-CoA reductase (31). Mevalonate is an intermedi- CD38 (anti-CD38-FITC, Immunotech, Marseilles, France) and ate in the synthesis of, among others, cholesterol, dolichol, and CD138 (anti-CD138-PE, Immunotech) by flow cytometric the isoprenoid molecules FPP and GGPP. Inhibitors of HMG- analysis (FACSCalibur, Becton Dickinson Immunocytometry CoA reductase, such as lovastatin, are widely used to treat Systems, Erembodegem, Belgium). Except for patient 3, who had patients with hypercholesterolemia (32). 96% myeloma cells in her bone marrow, tumor cells were purified In this report, we show that inhibition of protein ex vivo by magnetic cell sorting (Miltenyi Biotec, Bergisch geranylgeranylation either by depletion of GGPP by lovastatin Gladbach, Germany) based on CD138 expression as described or by specific inhibition of geranylgeranyl transferase I activity previously (36). Samples obtained in this way contained >95% inhibits proliferation of myeloma cells. Furthermore, our data myeloma plasma cells as determined by analysis of CD38/CD138 suggest that the geranylgeranylated GTP-binding protein Rac-1 coexpression. For experiments, myeloma cells were resuspended is involved in the control of myeloma cell growth. in growth medium (see above). Approval was obtained from the University Medical Center Utrecht Institutional Review Board for MATERIALS AND METHODS these studies (01/051-E). This study was done according to the Reagents Helsinki agreement. Lovastatin and simvastatin were obtained from Merck Cell Proliferation & Co., Inc. (Rahway, NJ) and chemically activated by alkaline Myeloma cells (3 Â 104) were seeded in 96-well flat- hydrolysis before use as described previously (33). Mevalonate bottomed plates (Nunc, Roskilde, Denmark) in 100 AL growth and farnesol were purchased from Sigma (St. Louis, MO), and medium with different concentrations of lovastatin (for concen- geranylgeraniol was obtained from ICN Biomedicals BV trations, see figure legends) alone or in the presence of (Zoetermeer, the Netherlands). FTI-277 (Calbiochem, mevalonate, farnesol, or geranylgeraniol. Fixed concentrations Schwallbach, Germany) and GGTI-298 (Calbiochem) are of mevalonate (100 Amol/L), farnesol (10 Amol/L), or geranyl- CAAX peptidomimetics, which are highly selective inhibitors geraniol (10 Amol/L) were used. These concentrations have of farnesyl transferase and geranylgeranyl transferase I, proven to be optimal in rescuing myeloma cells from lovastatin- respectively. Tat-Rac-1 Q61L (constitutively active) and Tat- induced inhibition of proliferation. Specific inhibition of farnesyl Rac-1 N17 (dominant-negative) vectors (34) were a kind gift of transferase and geranylgeranyl transferase I was accomplished Dr. S. Dowdy (Howard Hughes Medical Institute, Department of with FTI-277 and GGTI-298, respectively (for concentrations, Pathology, Washington University School of Medicine, St. Louis, see figure legends; ref. 37). C. difficile toxin B specifically MO). The Clostridium botulinum C3 exoenzyme was purchased inhibits Rho, Rac, and Cdc42 GTPases (38, 39), whereas C. from List Biological Laboratories, Inc. (Campbell, CA), and botulinum
Recommended publications
  • A Chemical Proteomic Approach to Investigate Rab Prenylation in Living Systems
    A chemical proteomic approach to investigate Rab prenylation in living systems By Alexandra Fay Helen Berry A thesis submitted to Imperial College London in candidature for the degree of Doctor of Philosophy of Imperial College. Department of Chemistry Imperial College London Exhibition Road London SW7 2AZ August 2012 Declaration of Originality I, Alexandra Fay Helen Berry, hereby declare that this thesis, and all the work presented in it, is my own and that it has been generated by me as the result of my own original research, unless otherwise stated. 2 Abstract Protein prenylation is an important post-translational modification that occurs in all eukaryotes; defects in the prenylation machinery can lead to toxicity or pathogenesis. Prenylation is the modification of a protein with a farnesyl or geranylgeranyl isoprenoid, and it facilitates protein- membrane and protein-protein interactions. Proteins of the Ras superfamily of small GTPases are almost all prenylated and of these the Rab family of proteins forms the largest group. Rab proteins are geranylgeranylated with up to two geranylgeranyl groups by the enzyme Rab geranylgeranyltransferase (RGGT). Prenylation of Rabs allows them to locate to the correct intracellular membranes and carry out their roles in vesicle trafficking. Traditional methods for probing prenylation involve the use of tritiated geranylgeranyl pyrophosphate which is hazardous, has lengthy detection times, and is insufficiently sensitive. The work described in this thesis developed systems for labelling Rabs and other geranylgeranylated proteins using a technique known as tagging-by-substrate, enabling rapid analysis of defective Rab prenylation in cells and tissues. An azide analogue of the geranylgeranyl pyrophosphate substrate of RGGT (AzGGpp) was applied for in vitro prenylation of Rabs by recombinant enzyme.
    [Show full text]
  • C-Terminal Proteolysis of Prenylated Proteins in Trypanosomatids And
    Molecular & Biochemical Parasitology 153 (2007) 115–124 C-terminal proteolysis of prenylated proteins in trypanosomatids and RNA interference of enzymes required for the post-translational processing pathway of farnesylated proteins John R. Gillespie a, Kohei Yokoyama b,∗, Karen Lu a, Richard T. Eastman c, James G. Bollinger b,d, Wesley C. Van Voorhis a,c, Michael H. Gelb b,d, Frederick S. Buckner a,∗∗ a Department of Medicine, University of Washington, 1959 N.E. Pacific St., Seattle, WA 98195, USA b Department of Chemistry, University of Washington, Seattle, WA 98195, USA c Department of Pathobiology, University of Washington, Seattle, Washington 98195, USA d Department of Biochemistry, University of Washington, Seattle, Washington 98195, USA Received 22 December 2006; received in revised form 17 February 2007; accepted 26 February 2007 Available online 1 March 2007 Abstract The C-terminal “CaaX”-motif-containing proteins usually undergo three sequential post-translational processing steps: (1) attachment of a prenyl group to the cysteine residue; (2) proteolytic removal of the last three amino acids “aaX”; (3) methyl esterification of the exposed ␣-carboxyl group of the prenyl-cysteine residue. The Trypanosoma brucei and Leishmania major Ras converting enzyme 1 (RCE1) orthologs of 302 and 285 amino acids-proteins, respectively, have only 13–20% sequence identity to those from other species but contain the critical residues for the activity found in other orthologs. The Trypanosoma brucei a-factor converting enzyme 1 (AFC1) ortholog consists of 427 amino acids with 29–33% sequence identity to those of other species and contains the consensus HExxH zinc-binding motif. The trypanosomatid RCE1 and AFC1 orthologs contain predicted transmembrane regions like other species.
    [Show full text]
  • The Protein Lipidation and Its Analysis
    Triola, J Glycom Lipidom 2011, S:2 DOI: 10.4172/2153-0637.S2-001 Journal of Glycomics & Lipidomics Research Article Open Access The Protein Lipidation and its Analysis Gemma Triola Department of Chemical Biology, Max Planck Institute of Molecular Physiology, Otto-Hahn-Strasse 11, 44227 Dortmund, Germany Abstract Protein Lipidation is essential not only for membrane binding but also for the interaction with effectors and the regulation of signaling processes, thereby playing a key role in controlling protein localization and function. Cholesterylation, the attachment of the glycosylphosphatidylinositol anchor, as well as N-myristoylation, S-prenylation and S-acylation are among the most relevant protein lipidation processes. Little is still known about the significance of the high diversity in lipid modifications as well as the mechanism by which lipidation controls function and activity of the proteins. Although the development of new strategies to uncover these and other unexplored topics is in great demand, important advances have already been achieved during the last years in the analysis of protein lipidation. This review will highlight the most prominent lipid modifications encountered in proteins and will provide an overview of the existing methods for the analysis and identification of lipid modified proteins. Introduction new tools and strategies. As such, this review will highlight the most prominent lipid modifications encountered in proteins and will provide Biological cell membranes are typically formed by mixtures an overview of the existing methods for the analysis and identification of lipids and proteins. Whereas the major lipid components are of lipid modified proteins detailing their advantages and limitations. glycerophospholipids, cholesterol and sphingolipids, proteins located in the membrane can be divided in two main classes, integral proteins Types of Lipidation and associated proteins.
    [Show full text]
  • Glycosylphosphatidylinositol-Anchored Proteins As Chaperones and Co-Receptors for FERONIA Receptor Kinase Signaling in Arabidops
    RESEARCH ARTICLE elifesciences.org Glycosylphosphatidylinositol-anchored proteins as chaperones and co-receptors for FERONIA receptor kinase signaling in Arabidopsis Chao Li1, Fang-Ling Yeh1†, Alice Y Cheung1,2,3*, Qiaohong Duan1, Daniel Kita1,2‡, Ming-Che Liu1,4, Jacob Maman1, Emily J Luu1, Brendan W Wu1§, Laura Gates1¶, Methun Jalal1, Amy Kwong1, Hunter Carpenter1, Hen-Ming Wu1,2* 1Department of Biochemistry and Molecular Biology, University of Massachusetts, Amherst, United States; 2Molecular and Cell Biology Program, University of 3 *For correspondence: acheung@ Massachusetts, Amherst, United States; Plant Biology Graduate Program, University 4 biochem.umass.edu (AYC); of Massachusetts, Amherst, United States; Graduate Institute of Biotechnology, [email protected] National Chung Hsing University, Tai Chung, Taiwan (HMW) Present address: †Clinical Research Center, Chung Shan Medical University Hospital, Abstract The Arabidopsis receptor kinase FERONIA (FER) is a multifunctional regulator for Taichung, Taiwan; ‡Department plant growth and reproduction. Here we report that the female gametophyte-expressed of Vascular Biology, University of glycosylphosphatidylinositol-anchored protein (GPI-AP) LORELEI and the seedling-expressed Connecticut Health Center, LRE-like GPI-AP1 (LLG1) bind to the extracellular juxtamembrane region of FER and show that this Farmington, United States; interaction is pivotal for FER function. LLG1 interacts with FER in the endoplasmic reticulum and on § Department of Immunology, the cell surface, and loss
    [Show full text]
  • Protein Prenylation in Plant Stress Responses
    molecules Review Protein Prenylation in Plant Stress Responses Michal Hála * and Viktor Žárský Department of Experimental Plant Biology, Faculty of Science, Charles University, Viniˇcná 5, 128 44 Prague, Czech Republic; [email protected] * Correspondence: [email protected]; Tel.: +420-221951686 Academic Editors: Ewa Swiezewska and Liliana Surmacz Received: 30 September 2019; Accepted: 25 October 2019; Published: 30 October 2019 Abstract: Protein prenylation is one of the most important posttranslational modifications of proteins. Prenylated proteins play important roles in different developmental processes as well as stress responses in plants as the addition of hydrophobic prenyl chains (mostly farnesyl or geranyl) allow otherwise hydrophilic proteins to operate as peripheral lipid membrane proteins. This review focuses on selected aspects connecting protein prenylation with plant responses to both abiotic and biotic stresses. It summarizes how changes in protein prenylation impact plant growth, deals with several families of proteins involved in stress response and highlights prominent regulatory importance of prenylated small GTPases and chaperons. Potential possibilities of these proteins to be applicable for biotechnologies are discussed. Keywords: plants; stress; protein prenyl transferases; prenylated proteins 1. Introduction to Protein Prenylation in Plants Protein prenylation (i.e., addition of one or more isoprenoid side chains) is one of the key post-translational protein modifications which contributes significantly to the regulation of life processes at the lipid membrane-protein interface in most organisms. Such hydrophobic modifications permit otherwise hydrophilic proteins to operate as peripheral membrane proteins (for a general overview, see [1–3]). Despite our focus on intensely studied protein prenylation in eukaryotes, it seems to be important for prokaryotic cells as well.
    [Show full text]
  • Lack of the Consensus Sequence Necessary for Tryptophan Prenylation in the Comx Pheromone Precursor
    Biosci. Biotechnol. Biochem., 76 (8), 1492–1496, 2012 Lack of the Consensus Sequence Necessary for Tryptophan Prenylation in the ComX Pheromone Precursor y Fumitada TSUJI,1; Ayako ISHIHARA,1 Aya NAKAGAWA,1 Masahiro OKADA,2 Shigeyuki KITAMURA,1 Kyoko KANAMARU,1 Yuichi MASUDA,3 Kazuma MURAKAMI,3 Kazuhiro IRIE,3 and Youji SAKAGAMI1 1Graduate School of Bioagricultural Sciences, Nagoya University, Chikusa-ku, Nagoya, Aichi 464-8601, Japan 2Graduate School of Bioscience and Biotechnology, Chubu University, Kasugai, Aichi 487-8501, Japan 3Graduate School of Agriculture, Kyoto University, Kyoto 606-8502, Japan Received March 19, 2012; Accepted May 7, 2012; Online Publication, August 7, 2012 [doi:10.1271/bbb.120206] ComX, an oligopeptide pheromone that stimulates the pheromones from other strains also contain either natural genetic competence controlled by quorum geranyl- or farnesyl-modified tryptophan residues. sensing in Bacillus subtilis and related bacilli, contains Prenyl post-translational modification is essential for a prenyl-modified tryptophan residue. Since ComX is the biological activity of the ComX pheromone.5–8) the only protein known to contain prenylated trypto- Apart from ComX, however, no other proteins contain- phan, the universality of this unique posttranslational ing prenylated tryptophan residues have so far been modification has yet to be determined. Recently, we identified. developed a cell-free assay system in which the trypto- Prenylation (farnesylation and geranylgeranylation) phan residue in the ComXRO-E-2 pheromone precursor of proteins on cysteine residues is a well-known post- derived from B. subtilis strain RO-E-2 can be gerany- translational modification. Prenyl modification of cys- lated by the ComQRO-E-2 enzyme.
    [Show full text]
  • Characterization of Prenylated C-Terminal Peptides Using a Novel Capture Technique
    bioRxiv preprint doi: https://doi.org/10.1101/2020.01.15.908152; this version posted January 15, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. TITLE: Characterization of Prenylated C-terminal Peptides Using a Novel Capture Technique Coupled with LCMS Running Title: Characterization of prenylated peptides from mouse brain James A. Wilkins*, Krista Kaasik, Robert J. Chalkley and Al L. Burlingame From the Mass Spectrometry Facility, Department of Pharmaceutical Chemistry, University of California, San Francisco, 600 16th Street, Rm N472, San Francisco, CA 94158 * Corresponding author; email address: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.01.15.908152; this version posted January 15, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Characterization of prenylated peptides from mouse brain 2 bioRxiv preprint doi: https://doi.org/10.1101/2020.01.15.908152; this version posted January 15, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Characterization of prenylated peptides from mouse brain ABSTRACT Post-translational modifications play a critical and diverse role in regulating cellular activities.
    [Show full text]
  • A User's Guide to Cell-Free Protein Synthesis
    Review A User’s Guide to Cell-Free Protein Synthesis Nicole E. Gregorio 1,2 , Max Z. Levine 1,3 and Javin P. Oza 1,2,* 1 Center for Applications in Biotechnology, California Polytechnic State University, San Luis Obispo, CA 93407, USA; [email protected] (N.E.G.); [email protected] (M.Z.L.) 2 Department of Chemistry and Biochemistry, California Polytechnic State University, San Luis Obispo, CA 93407, USA 3 Department of Biological Sciences, California Polytechnic State University, San Luis Obispo, CA 93407, USA * Correspondence: [email protected]; Tel.: +1-805-756-2265 Received: 15 February 2019; Accepted: 6 March 2019; Published: 12 March 2019 Abstract: Cell-free protein synthesis (CFPS) is a platform technology that provides new opportunities for protein expression, metabolic engineering, therapeutic development, education, and more. The advantages of CFPS over in vivo protein expression include its open system, the elimination of reliance on living cells, and the ability to focus all system energy on production of the protein of interest. Over the last 60 years, the CFPS platform has grown and diversified greatly, and it continues to evolve today. Both new applications and new types of extracts based on a variety of organisms are current areas of development. However, new users interested in CFPS may find it challenging to implement a cell-free platform in their laboratory due to the technical and functional considerations involved in choosing and executing a platform that best suits their needs. Here we hope to reduce this barrier to implementing CFPS by clarifying the similarities and differences amongst cell-free platforms, highlighting the various applications that have been accomplished in each of them, and detailing the main methodological and instrumental requirement for their preparation.
    [Show full text]
  • Role for Protein Prenylation and "CAAX" Processing in Photoreceptor Neurons
    Graduate Theses, Dissertations, and Problem Reports 2016 Role for protein prenylation and "CAAX" processing in photoreceptor neurons Nachiket D. Pendse Follow this and additional works at: https://researchrepository.wvu.edu/etd Recommended Citation Pendse, Nachiket D., "Role for protein prenylation and "CAAX" processing in photoreceptor neurons" (2016). Graduate Theses, Dissertations, and Problem Reports. 6397. https://researchrepository.wvu.edu/etd/6397 This Dissertation is protected by copyright and/or related rights. It has been brought to you by the The Research Repository @ WVU with permission from the rights-holder(s). You are free to use this Dissertation in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/ or on the work itself. This Dissertation has been accepted for inclusion in WVU Graduate Theses, Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU. For more information, please contact [email protected]. Role for protein prenylation and “CAAX” processing in photoreceptor neurons Nachiket D. Pendse Dissertation submitted to the Department of Biology at West Virginia University in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biology Visvanathan Ramamurthy, Ph.D., Chair Maxim Sokolov, Ph.D. Peter Mathers, Ph.D. Andrew Dacks, Ph.D. Shuo Wei, Ph.D. Graduate Program in Biology West Virginia University School of Medicine Morgantown, West Virginia 2016 Key Words: Prenylation, photoreceptor neurons, retina, phototransduction and vision Copyright 2016 Nachiket Pendse ABSTRACT Role for protein prenylation and “CAAX” processing in photoreceptor neurons Nachiket D.
    [Show full text]
  • Isoprenylcysteine Carboxylmethyltransferase Regulates Mitochondrial Respiration and Cancer Cell Metabolism
    Oncogene (2015) 34, 3296–3304 © 2015 Macmillan Publishers Limited All rights reserved 0950-9232/15 www.nature.com/onc ORIGINAL ARTICLE Isoprenylcysteine carboxylmethyltransferase regulates mitochondrial respiration and cancer cell metabolism JT Teh1,5, WL Zhu1,2,5, OR Ilkayeva3,YLi4, J Gooding3, PJ Casey1, SA Summers4, CB Newgard3 and M Wang1,2 Isoprenylcysteine carboxylmethyltransferase (Icmt) catalyzes the last of the three-step posttranslational protein prenylation process for the so-called CaaX proteins, which includes many signaling proteins, such as most small GTPases. Despite extensive studies on Icmt and its regulation of cell functions, the mechanisms of much of the impact of Icmt on cellular functions remain unclear. Our recent studies demonstrated that suppression of Icmt results in induction of autophagy, inhibition of cell growth and inhibition of proliferation in various cancer cell types, prompting this investigation of potential metabolic regulation by Icmt. We report here the findings that Icmt inhibition reduces the function of mitochondrial oxidative phosphorylation in multiple cancer cell lines. In-depth oximetry analysis demonstrated that functions of mitochondrial complex I, II and III are subject to Icmt regulation. Consistently, Icmt inhibition decreased cellular ATP and depleted critical tricarboxylic acid cycle metabolites, leading to suppression of cell anabolism and growth, and marked autophagy. Several different approaches demonstrated that the impact of Icmt inhibition on cell proliferation and viability was
    [Show full text]
  • Not So Slim Anymore—Evidence for the Role of SUMO in the Regulation of Lipid Metabolism
    biomolecules Review Not So Slim Anymore—Evidence for the Role of SUMO in the Regulation of Lipid Metabolism Amir Sapir Department of Biology and the Environment, Faculty of Natural Sciences, University of Haifa–Oranim, Tivon 36006, Israel; [email protected]; Tel.: +972-495-396-15 Received: 2 June 2020; Accepted: 3 August 2020; Published: 6 August 2020 Abstract: One of the basic building blocks of all life forms are lipids—biomolecules that dissolve in nonpolar organic solvents but not in water. Lipids have numerous structural, metabolic, and regulative functions in health and disease; thus, complex networks of enzymes coordinate the different compositions and functions of lipids with the physiology of the organism. One type of control on the activity of those enzymes is the conjugation of the Small Ubiquitin-like Modifier (SUMO) that in recent years has been identified as a critical regulator of many biological processes. In this review, I summarize the current knowledge about the role of SUMO in the regulation of lipid metabolism. In particular, I discuss (i) the role of SUMO in lipid metabolism of fungi and invertebrates; (ii) the function of SUMO as a regulator of lipid metabolism in mammals with emphasis on the two most well-characterized cases of SUMO regulation of lipid homeostasis. These include the effect of SUMO on the activity of two groups of master regulators of lipid metabolism—the Sterol Regulatory Element Binding Protein (SERBP) proteins and the family of nuclear receptors—and (iii) the role of SUMO as a regulator of lipid metabolism in arteriosclerosis, nonalcoholic fatty liver, cholestasis, and other lipid-related human diseases.
    [Show full text]
  • Investigating the Regulation of Ras Protein Prenylation By
    Investigating the Regulation of Ras Protein Prenylation by Desirée García-Torres A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Chemical Biology) in The University of Michigan 2019 Doctoral Committee: Professor Emerita Carol A. Fierke, Co-Chair Professor Anna K. Mapp, Co-Chair Assistant Professor Brent R. Martin Associate Professor Patrick J. O’Brien i Desirée García-Torres [email protected] ORCID iD: 0000-0001-7293-9402 © Desirée García-Torres 2019 i ACKNOWLEDGMENTS This thesis work would not have been possible without the support and guidance of many people throughout my scientific journey. First, I want to thank my thesis advisor, Dr. Carol A. Fierke, for her great mentorship, for allowing me to have the creative liberty to explore the scientific unknown, and for believing that I could successfully achieve this milestone. I want to thank my undergraduate research advisors, Dr. Carlos Cabrera, Dr. Carlos Hangarter, and Dr. Yihua Liu. You all instilled this never-ending sense of curiosity for science that contributed to my decision to pursue a doctoral degree. I also want to thank my committee members for their advice and assistance during my thesis research. I want to thank past and present members of the Fierke laboratory. I want to give special thanks to Dr. Benjamin C. Jennings. You took me under your wing, shared with me that curiosity to know more about how small GTPases are regulated, and gave me the tools to pursue my research interests. I will never forget your words: “It is not about working hard, it is about working smart.” I also want to thank Kelsey Diffley, Andrea Stoddard, Dr.
    [Show full text]